- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Apr 29, 2026 | 59.12M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 59.2M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 59.2M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 58.5M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 58.2M sh |
| Dividends Paid | Q2 2026 · Mar 31, 2026 | $96.1M |
| Dividends Paid | Q2 2026 · Mar 31, 2025 | $90M |
| Capex | Q2 2026 · Mar 31, 2026 | $395M |
| Capex | Q2 2026 · Mar 31, 2025 | $479.2M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | $491.4M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | $453.8M |
| Long Term Debt | Q2 2026 · Mar 31, 2026 | $5.76B |
| Long Term Debt | Q2 2026 · Sep 30, 2025 | $3.37B |
| Long Term Debt | Q2 2026 · Mar 31, 2025 | $3.35B |
| Short Term Debt | Q2 2026 · Mar 31, 2026 | $1.96B |
| Short Term Debt | Q2 2026 · Sep 30, 2025 | $1.32B |
| Short Term Debt | Q2 2026 · Mar 31, 2025 | $1.02B |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $49.5M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $5.7M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2025 | $15.2M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $3.42B |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $3.43B |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $3.39B |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $3.51B |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | $3.31B |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $3.23B |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $2.91B |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $2.55B |
| Current Liabilities restated | Q2 2026 · Mar 31, 2025 | $2.11B |
| Current Assets | Q2 2026 · Mar 31, 2026 | $1.59B |
| Current Assets | Q2 2026 · Sep 30, 2025 | $807.9M |
| Current Assets restated | Q2 2026 · Mar 31, 2025 | $908M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $14.67B |
| Total Assets | Q2 2026 · Sep 30, 2025 | $11.58B |
| Total Assets | Q2 2026 · Mar 31, 2025 | $11.35B |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $4.60 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $6.14 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $3.51 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $4.86 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $4.61 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $6.16 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $3.52 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $4.88 |
| Net Income | Q2 2026 · Mar 31, 2026 | $282.2M |
| Net Income | Q2 2026 · Mar 31, 2026 | $377.2M |
| Net Income | Q2 2026 · Mar 31, 2025 | $209.3M |
| Net Income | Q2 2026 · Mar 31, 2025 | $290.6M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $303.5M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $465.4M |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | $277.9M |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | $412.8M |